Biodesix, Inc. (BDSX)
Healthcare • Diagnostics & Research
StockNasdaqGMUnited StatesUS09075X2071
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Biodesix, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:26. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 16:00 | -0.52 | — | — | Upcoming |
| 05 Nov 2026 16:00 | -0.75 | -0.75 | -0.2% | In line |
| 05 Aug 2026 16:00 | -0.90 | -0.71 | +21.4% | Beat |
| 04 May 2026 16:00 | -1.10 | -0.81 | +26.1% | Beat |
| 26 Feb 2026 16:00 | -0.87 | -0.49 | +43.4% | Beat |
| 03 Nov 2025 16:00 | -1.51 | -1.16 | +23.0% | Beat |
| 07 Aug 2025 16:00 | -1.37 | -1.60 | -17.1% | Miss |
| 13 May 2025 16:00 | -1.40 | -1.60 | -14.3% | Miss |
| 03 Mar 2025 16:00 | -1.33 | -1.20 | +10.0% | Beat |
| 01 Nov 2024 06:00 | -1.52 | -1.40 | +7.9% | Beat |
| 07 Aug 2024 16:00 | -1.84 | -1.60 | +13.0% | Beat |
| 08 May 2024 16:00 | -2.87 | -2.80 | +2.3% | Beat |
| 01 Mar 2024 06:00 | -2.20 | -2.00 | +9.1% | Beat |
| 07 Nov 2023 16:00 | -3.00 | -2.80 | +6.7% | Beat |
| 07 Aug 2023 16:00 | -4.13 | -3.40 | +17.7% | Beat |
| 11 May 2023 16:00 | -4.73 | -4.80 | -1.4% | Miss |
| 06 Mar 2023 06:00 | -5.55 | -7.00 | -26.1% | Miss |
| 03 Nov 2022 06:00 | -6.55 | -6.80 | -3.8% | Miss |
| 04 Aug 2022 06:00 | -9.30 | -8.00 | +14.0% | Beat |
| 11 May 2022 06:00 | -8.50 | -10.00 | -17.7% | Miss |
| 14 Mar 2022 06:00 | -9.85 | -9.80 | +0.5% | In line |
| 15 Nov 2021 07:00 | -9.55 | -8.20 | +14.1% | Beat |
| 10 Aug 2021 16:00 | -5.80 | -8.20 | -41.4% | Miss |
| 11 May 2021 16:00 | -3.50 | -5.20 | -48.6% | Miss |
| 16 Mar 2021 15:00 | -10.00 | -5.07 | +49.3% | Beat |
| 10 Dec 2020 16:00 | -5.00 | -6.60 | -32.0% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 88.5M | +24.1% | -35.3M | -39.8% | -4.67 | +29.2% | -23.7M |
| 2024 | 71.3M | +45.3% | -42.9M | -60.2% | -6.60 | +48.4% | -52.1M |
| 2023 | 49.1M | +28.5% | -52.1M | -106.2% | -12.80 | +58.7% | -45.9M |
| 2022 | 38.2M | — | -65.4M | -171.3% | -31.00 | — | -48.5M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 8.32 | 11.32 | 7.70 | 10.66 | +24.97% | 2,512,622 | |
| 02 Nov 2026 – 06 Nov 2026 | 23.24 | 23.31 | 7.96 | 8.53 | -63.32% | 2,034,800 | |
| 26 Oct 2026 – 30 Oct 2026 | 21.54 | 25.06 | 20.11 | 23.25 | +9.80% | 441,100 | |
| 19 Oct 2026 – 23 Oct 2026 | 23.68 | 25.24 | 21.11 | 21.18 | -10.48% | 437,300 | |
| 12 Oct 2026 – 16 Oct 2026 | 26.02 | 26.62 | 22.60 | 23.66 | -9.07% | 290,000 | |
| 05 Oct 2026 – 09 Oct 2026 | 27.72 | 30.00 | 25.10 | 26.02 | -6.13% | 483,700 | |
| 28 Sep 2026 – 02 Oct 2026 | 29.00 | 31.97 | 26.33 | 27.72 | -4.74% | 811,800 | |
| 21 Sep 2026 – 25 Sep 2026 | 29.36 | 31.35 | 27.56 | 29.10 | -0.34% | 467,200 | |
| 14 Sep 2026 – 18 Sep 2026 | 26.80 | 29.96 | 25.75 | 29.20 | +8.29% | 386,600 | |
| 08 Sep 2026 – 11 Sep 2026 | 25.97 | 27.90 | 25.60 | 26.97 | +3.00% | 219,700 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Biodesix, Inc. (BDSX) Presents at 2026 UBS Global Healthcare Conference Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 16:50
- Biodesix to Showcase MRD Strategy at the Association for Molecular Pathology (AMP) 2026 Annual Meeting (opens in a new tab) 09 Nov 2026 11:00
- HC Wainwright & Co. Maintains Buy on Biodesix, Lowers Price Target to $34 (opens in a new tab) Benzinga · 09 Nov 2026 07:34
- Lake Street Maintains Buy on Biodesix, Lowers Price Target to $30 (opens in a new tab) Benzinga · 06 Nov 2026 21:30
- Biodesix (BDSX) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 06 Nov 2026 15:31
- Champions Oncology vs. Biodesix: Which Oncology Stock Is a Better Buy? (opens in a new tab) Zacks · 06 Nov 2026 15:16
- Biodesix Inc (BDSX) (Q3 2026) Earnings Call Highlights: Revenue Growth Offset by Sales Force ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 05:27
- Biodesix Stock Crashes Nearly 30% After Q3 Revenue Miss, Slashes 2026 Outlook (opens in a new tab) Benzinga · 06 Nov 2026 04:24
- Biodesix, Inc. (BDSX) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 06 Nov 2026 03:14
- What Biodesix (BDSX) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 05 Nov 2026 23:14
- Biodesix, Inc. (BDSX) Reports Q3 Loss, Lags Revenue Estimates (opens in a new tab) Zacks · 05 Nov 2026 21:45
- Biodesix Announces Third Quarter 2026 Results and Highlights (opens in a new tab) 05 Nov 2026 21:01
- Biodesix Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 05 Nov 2026 18:35
- Biodesix Lowers FY2026 Sales Guidance from $108.000M-$114.000M to $101.000M-$103.000M vs $111.817M Est (opens in a new tab) Benzinga · 05 Nov 2026 17:03
- Biodesix to Participate in Upcoming Investor Conferences (opens in a new tab) 04 Nov 2026 11:00
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 9.79 USD
- Market cap
- 108.6M
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow BDSX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.